Literature DB >> 8814435

5-Fluorouracil- and levamisole-associated multifocal leukoencephalopathy.

G Galassi1, G Tassone, M Sintini, M Spagnoli, L Bertolani, L Mavilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8814435     DOI： 10.1159/000117263

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  3 in total

1.  Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.

Authors:  Jérémy T Campillo; Céline Eiden; Michel Boussinesq; Sébastien D S Pion; Jean-Luc Faillie; Cédric B Chesnais
Journal:  Br J Clin Pharmacol       Date:  2021-09-15       Impact factor: 3.716

2.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22

3.  Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation.

Authors:  Álvaro Sebastián-Serrano; Tobias Engel; Laura de Diego-García; Luis A Olivos-Oré; Marina Arribas-Blázquez; Carlos Martínez-Frailes; Carmen Pérez-Díaz; José Luis Millán; Antonio R Artalejo; María Teresa Miras-Portugal; David C Henshall; Miguel Díaz-Hernández
Journal:  Hum Mol Genet       Date:  2016-07-27       Impact factor: 6.150
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.